Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burden

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Pharmacoepidemiology and Drug Safety|July 18, 2015
Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.
Cancer Research|August 25, 2011
Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detailSusan M Burden-Gulley, Mohammed Q Qutaish, Kristin E Sullivant, et al.
BMJ (Clinical Research Ed.)|July 15, 2016
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
Bone|February 21, 2018
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary diseaseOlorunfemi A Oshagbemi, Andrea M Burden, Kimberly N Shudofsky, et al.
Pharmacoepidemiology and Drug Safety|September 29, 2018
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortalityOlorunfemi A Oshagbemi, Frits M E Franssen, Dionne C W Braeken, et al.
International Journal of Cancer|September 19, 2012
Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmuSusan M Burden-Gulley, Mohammed Q Qutaish, Kristin E Sullivant, et al.
Calcified Tissue International|July 18, 2015
Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic DrugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.
Calcified Tissue International|April 21, 2015
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysisJohanna H M Driessen, Ronald M A Henry, Hein A W van Onzenoort, et al.
Neoplasia (New York, N.Y.)|April 3, 2010
A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase muSusan M Burden-Gulley, Theresa J Gates, Adam M Burgoyne, et al.
Analytical Chemistry|November 22, 2023
Confirming Silent Translocation through Nanopores with Simultaneous Single-Molecule Fluorescence and Single-Channel Electrical RecordingsDaniel L Burden, Joshua J Meyer, Richard D Michael, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Pharmacoepidemiology and Drug Safety|July 18, 2015
Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.
Cancer Research|August 25, 2011
Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detailSusan M Burden-Gulley, Mohammed Q Qutaish, Kristin E Sullivant, et al.
BMJ (Clinical Research Ed.)|July 15, 2016
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
Bone|February 21, 2018
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary diseaseOlorunfemi A Oshagbemi, Andrea M Burden, Kimberly N Shudofsky, et al.
Pharmacoepidemiology and Drug Safety|September 29, 2018
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortalityOlorunfemi A Oshagbemi, Frits M E Franssen, Dionne C W Braeken, et al.
International Journal of Cancer|September 19, 2012
Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmuSusan M Burden-Gulley, Mohammed Q Qutaish, Kristin E Sullivant, et al.
Calcified Tissue International|July 18, 2015
Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic DrugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.
Calcified Tissue International|April 21, 2015
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysisJohanna H M Driessen, Ronald M A Henry, Hein A W van Onzenoort, et al.
Neoplasia (New York, N.Y.)|April 3, 2010
A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase muSusan M Burden-Gulley, Theresa J Gates, Adam M Burgoyne, et al.
Analytical Chemistry|November 22, 2023
Confirming Silent Translocation through Nanopores with Simultaneous Single-Molecule Fluorescence and Single-Channel Electrical RecordingsDaniel L Burden, Joshua J Meyer, Richard D Michael, et al.
Pageof 19